Outersphere Approach to Increasing the Persistance of Oxygen-Sensitive Europium(II)-Containing Contrast Agents for Magnetic Resonance Imaging with Perfluorocarbon Nanoemulsions toward Imaging of Hypoxia

Adv Healthc Mater. 2023 Jul;12(19):e2203209. doi: 10.1002/adhm.202203209. Epub 2023 Mar 24.

Abstract

Radiographic mapping of hypoxia is needed to study a wide range of diseases. Complexes of Eu(II) are a promising class of molecules to fit this need, but they are generally limited by their rapid oxidation rates in vivo. Here, a perfluorocarbon-nanoemulsion perfused with N2 , forms an interface with aqueous layers to hinder oxidation of a new perfluorocarbon-soluble complex of Eu(II). Conversion of the perfluorocarbon solution of Eu(II) into nanoemulsions results in observable differences between reduced and oxidized forms by magnetic resonance imaging both in vitro and in vivo. Oxidation in vivo occurrs over a period of ≈30 min compared to <5 min for a comparable Eu(II)-containing complex without nanoparticle interfaces. These results represent a critical step toward delivery of Eu(II)-containing complexes in vivo for the study of hypoxia.

Keywords: Eu(II); MRI; hypoxia; perfluorocarbons.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Contrast Media
  • Europium*
  • Fluorocarbons*
  • Humans
  • Hypoxia
  • Magnetic Resonance Imaging / methods
  • Oxygen

Substances

  • Europium
  • Contrast Media
  • Oxygen
  • Fluorocarbons